Impacts of cachexia progression in addition to serum IgG and blood lymphocytes on serum nivolumab in advanced cancer patients [0.03%]
癌症晚期患者恶病质进展以及血清IgG和血液淋巴细胞对血清nivolumab的影响
Kazuki Abe,Kaito Shibata,Takafumi Naito et al.
Kazuki Abe et al.
Purpose: Serum nivolumab concentrations exhibit a large variation in cancer patients. Cancer cachexia inducing systemic inflammation promotes the elimination of endogenous proteins, while its association with serum nivolu...
Correction to: Current evidence on the impact of medication optimization or pharmacological interventions on frailty or aspects of frailty: a systematic review of randomized controlled trials [0.03%]
对药物优化或药理干预对脆弱性或脆弱性方面的随机对照试验的系统评价的影响的证据的更正通知
Farhad Pazan,Mirko Petrovic,Antonio Cherubini et al.
Farhad Pazan et al.
Hypertension and Covid-19 vaccines: are there any differences between the different vaccines? A safety signal [0.03%]
高血压与新冠疫苗：不同疫苗之间是否存在差异？一个安全性信号
Beatrice Bouhanick,François Montastruc,Samuel Tessier et al.
Beatrice Bouhanick et al.
The efficacy and safety of rivaroxaban in coronary artery disease patients with heart failure and sinus rhythm: a systematic review and meta-analysis [0.03%]
利伐沙班在心房颤动冠心病患者中疗效和安全性的系统评价和meta分析
Shanshan Xie,Jingjing Chen,Gang Xiong et al.
Shanshan Xie et al.
Purpose: To explore the efficacy and safety of rivaroxaban in patients with coronary artery disease (CAD), heart failure (HF) and sinus rhythm (SR). Metho...
External evaluation of published population pharmacokinetic models of polymyxin B [0.03%]
万古霉素群体药代动力学模型的外部评价
Ya-Qian Li,Kai-Feng Chen,Jun-Jie Ding et al.
Ya-Qian Li et al.
Objectives: Several population pharmacokinetics (popPK) models for polymyxin B have been constructed to optimize therapeutic regimens. However, their predictive performance remains unclear when extrapolated to different c...
Pharmacodynamic effects of indobufen compared with aspirin in patients with coronary atherosclerosis [0.03%]
吲布芬与阿司匹林对冠状动脉粥样硬化患者药理动力学影响的比较研究
Mingwen Yang,Zekang Ye,Lianlian Mei et al.
Mingwen Yang et al.
Purpose: This study aimed to investigate the pharmacodynamic effects of indobufen and low-dose aspirin in patients with coronary atherosclerosis. Methods:...
Randomized Controlled Trial
European journal of clinical pharmacology. 2021 Dec;77(12):1815-1823. DOI:10.1007/s00228-021-03177-y 2021
The pharmacokinetic interaction between nasally administered naloxone and the opioid remifentanil in human volunteers [0.03%]
关于纳洛酮和阿片类药物瑞米芬太尼在人体内的药动学相互作用研究
Ida Tylleskar,Sissel Skarra,Arne Kristian Skulberg et al.
Ida Tylleskar et al.
Purpose: Remifentanil has been shown to increase the bioavailability of nasally administered naloxone. The aim of this study was to explore the nature of this observation. ...
Unintentional guideline deviations in hospitalized patients with two or more antithrombotic agents: an intervention study [0.03%]
住院患者使用两种或以上抗凝药物的非故意偏离指导原则：一项干预研究
Renate C A E van Uden,Marcel P H van den Broek,Ilse Houtenbos et al.
Renate C A E van Uden et al.
Purpose: Treatment schedules for antithrombotic therapy are complex, and there is a risk of inappropriate prescribing or continuation of antithrombotic therapy beyond the intended period of time. The primary aim of this s...
Maternal paracetamol intake and fetal ductus arteriosus closure: adding pieces to the scenery [0.03%]
母体对乙酰氨基酚摄入与胎儿动脉导管闭合：增加风景中的元素
Karel Allegaert,Michael Ceulemans,John van den Anker
Karel Allegaert
Self-report instruments for assessing adherence to warfarin therapy: a systematic review [0.03%]
华法林治疗依从性自我评估工具的系统评价
Mayara Sousa Vianna,Marcus Fernando da Silva Praxedes,Vânia Eloisa de Araújo et al.
Mayara Sousa Vianna et al.
Background: The assessment of adherence to warfarin therapy is useful in clinical practice due to its wide variability in dose-response and risks of complications. The aim of this study was to investigate validated instru...